Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19

Completed

• Conditions: COVID-19; People Incarcerated

• Registration Number: NCT04380714
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

The SARS-CoV 2 pandemic started in China in December 2019, then reached France on January 24, 2020.

On March 14, France moved into phase 3 of the epidemic threshold with the implementation of containment measures on March 17 Measures were put in place by N.Belloubet (French Minister of Justice) from March 17, including suspension of visiting rooms and activities in detention.

Containment provides boredom and isolation with many potential consequences: sleep disturbance, anxiety, PTSD, depression, suicide, addictive behavior and violence.

However,prisoners have a higher prevalence of substance use disorders than the general population.

What will have been the impact of the confinement on the consumption of psychoactive substances by prisoners at the Villeneuve Les Maguelone prison.

* Anonymous questionnaire from the start

* Collection of socio-demographic data

* Collection of consumption data before and during containment

* Collection of monitoring data

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-01
• Study First Submitted: 2020-05-07
• Study First Submitted QC: 2020-05-07
• Study First Posted: 2020-05-08
• Primary Completion: 2020-05-30
• Study Completion: 2020-08-01
• Status Verified: 2020-12
• Last Update Submitted: 2020-12-28
• Last Update Posted: 2020-12-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 700

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
percentage changes in the consumption of psychoactive substances	1 day	percentage changes in the consumption of psychoactive substances

Secondary Outcome Measures

Name	Time	Method
Assessment of depression	1 day	Assessment of depression by self-administered questionnaire before / during confinement
Assessment of the level of stress	1 day	Assessment of the level of stress by self-administered questionnaire before / during confinement
Craving modification evaluation	1 day	Craving modification evaluation

Trial Locations

Locations (1)

UH Montpellier; 🇫🇷 Montpellier, France